Multicenter prospective cohort study on the risk prediction of metachronous gastric cancer after endoscopic resection by DNA methylation markers

Multicenter prospective cohort study on the risk prediction of metachronous gastric cancer after endoscopic resection by DNA methylation markers - Risk prediction of metachronous gastric cancer after endoscopic resection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016864

Enrollment

800

Registered

2015-03-23

Start date

2008-04-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who planned to have, or had undergone, endoscopic resection for primary gastric cancer.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from an untreated cancer 2. Active infection (Tempereture >=38 centigrade) 3. Active gastrointestinal bleeding 4. Bleeding tendency or coagulopathy 5. Patients considered unsuitable for endoscopy

Design outcomes

Primary

Measure	Time frame
Incidence rate of metachronous gastric cancer	—

Countries

Japan

Contacts

Public ContactSeiichiro Abe

National Cancer Center Hospital, Tokyo, Japan Endoscopy Division

seabe@ncc.go.jp+81-3-3542-2511

Outcome results